Natixis Advisors LLC Sells 22,308 Shares of Tenet Healthcare Co. (NYSE:THC)

Natixis Advisors LLC lowered its stake in Tenet Healthcare Co. (NYSE:THCFree Report) by 55.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 17,640 shares of the company’s stock after selling 22,308 shares during the quarter. Natixis Advisors LLC’s holdings in Tenet Healthcare were worth $2,226,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. True Wealth Design LLC bought a new stake in shares of Tenet Healthcare in the 3rd quarter valued at $38,000. WR Wealth Planners LLC grew its position in Tenet Healthcare by 2,836.4% in the 4th quarter. WR Wealth Planners LLC now owns 323 shares of the company’s stock valued at $41,000 after purchasing an additional 312 shares during the period. Smartleaf Asset Management LLC grew its position in Tenet Healthcare by 30.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 471 shares of the company’s stock valued at $59,000 after purchasing an additional 110 shares during the period. Kestra Investment Management LLC acquired a new stake in Tenet Healthcare in the 4th quarter valued at $60,000. Finally, Hantz Financial Services Inc. acquired a new stake in Tenet Healthcare in the 3rd quarter valued at $83,000. Institutional investors own 95.44% of the company’s stock.

Insider Activity at Tenet Healthcare

In other news, Director J Robert Kerrey sold 9,525 shares of the company’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the sale, the director now directly owns 27,378 shares in the company, valued at $3,434,022.54. This represents a 25.81 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.93% of the stock is currently owned by company insiders.

Analyst Ratings Changes

THC has been the subject of several research reports. StockNews.com raised shares of Tenet Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, March 13th. Barclays reduced their price target on shares of Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a research report on Thursday, February 13th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $177.00 price objective on shares of Tenet Healthcare in a report on Thursday, February 13th. KeyCorp cut their price objective on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Finally, Wells Fargo & Company downgraded shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $205.00 to $150.00 in a report on Monday, November 25th. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $163.88.

View Our Latest Research Report on Tenet Healthcare

Tenet Healthcare Trading Down 2.7 %

Shares of Tenet Healthcare stock opened at $122.87 on Monday. Tenet Healthcare Co. has a 52-week low of $90.03 and a 52-week high of $171.20. The stock’s 50-day simple moving average is $132.20 and its 200 day simple moving average is $143.15. The stock has a market capitalization of $11.69 billion, a P/E ratio of 3.81, a P/E/G ratio of 1.02 and a beta of 2.06. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78.

Tenet Healthcare (NYSE:THCGet Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. As a group, research analysts anticipate that Tenet Healthcare Co. will post 12.24 EPS for the current year.

Tenet Healthcare Profile

(Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Featured Articles

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THCFree Report).

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.